Rahul Sharma, PhD

Health Topics
It's time to recruit research labs in the COVID-19 fight
With medical professionals risking their lives to save others, it's time for healthcare systems to open their eyes to the potential for academic research labs to play a role.
April 8, 2020
2020 02 04 22 50 3305 Lab Pulse Second Opinion Logo Circlev2
Page 1 of 1
Top Stories
Researcher
Gene silencing and gene editing
Engineered Cas clears barrier to antiviral CRISPR therapies
Researchers have engineered a Cas enzyme to enhance activity against RNA viruses, resulting in a system that completely blocked the replication of various SARS-CoV-2 strains.
Artificial Intelligence Ai Binary Code Social
Artificial Intelligence
AI-powered endoscope doubles detection of high-risk esophageal lesions
Business Handshake Man Social
Mergers & Acquisitions
Bruker to acquire NanoString for $392.6M
Stock Exchange Social
Trends and Finance
DermTech receives delisting warning from Nasdaq
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Home
Engineered Cas clears barrier to antiviral CRISPR therapies
By Nick Paul Taylor
Researchers have engineered a Cas enzyme to enhance activity against RNA viruses, resulting in a system that completely blocked the replication of various SARS-CoV-2 strains.
April 19, 2024
Researcher
AI-powered endoscope doubles detection of high-risk esophageal lesions
By Nick Paul Taylor
Deep learning has doubled the detection of high-risk lesions during routine endoscopies in a clinical trial of more than 3,000 patients in China.
April 17, 2024
Artificial Intelligence Ai Binary Code Social
Bruker to acquire NanoString for $392.6M
By LabPulse.com staff writers
NanoString has reached an agreement with Bruker in which Bruker will purchase substantially all of NanoString's assets for approximately $392.6 million in cash, as well as assume certain NanoString liabilities.
April 18, 2024
Business Handshake Man Social
DermTech receives delisting warning from Nasdaq
By LabPulse.com staff writers
Melanoma diagnostics company DermTech announced that it has received a delisting warning from Nasdaq.
April 17, 2024
Stock Exchange Social
Veracyte to share bundle of genomic classifier studies at AUA 2024
By LabPulse.com staff writers
Veracyte has announced that the American Urological Association's May meeting will feature nine sessions related to evaluations of its prostate cancer and bladder cancer genomic tests.
April 16, 2024
Prostate Cancer 3 D Rendering Social
Nightingale Health to open U.S. lab, collaborate with Englander Institute at Weill Cornell
By LabPulse.com staff writers
Preventive healthcare company Nightingale Health will open a laboratory in the U.S. In addition, the Englander Institute for Precision Medicine at Weill Cornell Medicine has signed on as its first customer.
April 17, 2024
Blood Test Samples Lab Social
Co-Diagnostics opens manufacturing facility in Utah
By LabPulse.com staff writers
Molecular diagnostics firm Co-Diagnostics has opened a new manufacturing facility in South Salt Lake, UT, holding a ribbon-cutting event to inaugurate the facility on April 11.
April 16, 2024
Lab Vacutainer Test Tube Social
Babson adds hand-warming to blood testing mini-draws in Texas pharmacies
By LabPulse.com staff writers
Austin, TX-based Babson Diagnostics said it has received positive feedback for its hand-warmer, which is used as part of a finger-stick blood sample collection device in retail pharmacies.
April 16, 2024
Blood collection on the Babson Diagnostics hand-warmer.
OraSure discloses cybersecurity breach
By LabPulse.com staff writers
OraSure Technology disclosed a cybersecurity incident involving data theft that occurred in late March.
April 15, 2024
Cybersecurity Locks Social
Roche, Lilly Alzheimer's blood test granted FDA breakthrough device designation
By LabPulse.com staff writers
The Alzheimer's blood test developed through a collaboration between Roche and Lilly has been granted a breakthrough device designation by the U.S. Food and Drug Administration (FDA).
April 11, 2024
Alzheimers Tau Tangles Social
Lipid enzyme blocker renders prostate cancer cells vulnerable to PARP inhibitors in study
By Nick Paul Taylor
Blocking lipid synthesis enhanced the effect of PARP inhibitors on prostate cancer in a preclinical study, pointing to a potential way to make the treatments effective in more patients.
April 15, 2024
Cancer Cells Prostate Social
European Commission approves Illumina's plan to divest Grail
By LabPulse.com staff writers
The European Commission has approved Illumina's plan to divest multicancer early detection test maker Grail under the European Union Merger Regulation adopted by the EC in October 2023.
April 12, 2024
Eu Flag European Commission Brussels Social
Page 1 of 116
Next Page